Quanterix

Akoya Biosciences is a life sciences company specializing in spatial biology. It provides end-to-end solutions for high-parameter tissue analysis across discovery, translational research, and clinical applications, supporting the development of more precise therapies in immuno-oncology and other drug areas. The company offers two main platforms: PhenoCycler (formerly CODEX), a benchtop system capable of quantifying more than 40 biomarkers for biomarker discovery, and PhenoImager (formerly Phenoptics), an end-to-end multiplexed immunofluorescence platform designed for robust, high-throughput translational research and clinical trials. Its offerings include reagents, software, and services to enable tissue analysis and spatial phenotyping across the research continuum.

Emission Inc. specializes in manufacturing cytometry instruments and reagents for measuring fluorescence in bead-based biological assays. Their product range includes dye-encapsulating magnetic beads suitable for low and mid-plex assays, and a mid-plex platform designed to read these proprietary beads. The company's mission is to make multiplex assays more accessible and affordable by providing higher-performance instruments and reagents.

UmanDiagnostics is a biopharmaceutical company focused on advancing diagnostics for neurodegenerative diseases. It specializes in providing neurofilament light (Nf-L) antibodies and ELISA kits, which facilitate the rapid quantification of Nf-L in cerebrospinal fluid. This technology enables healthcare professionals to accurately diagnose various neurological conditions and traumatic brain injuries. By offering tools that streamline the detection process, UmanDiagnostics supports the development of therapeutics aimed at addressing these complex health issues.